Pityriasis rosea and COVID-19.
作者信息
Veraldi Stefano, Spigariolo Cristina B
机构信息
Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS Ca' Granda Ospedale Maggiore, Policlinico.
出版信息
J Med Virol. 2021 Jul;93(7):4068. doi: 10.1002/jmv.26679. Epub 2020 Dec 1.
Abstract
摘要
相似文献
1
Pityriasis rosea and COVID-19.
J Med Virol. 2021 Jul;93(7):4068. doi: 10.1002/jmv.26679. Epub 2020 Dec 1.
2
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
3
Pityriasis Rosea after COVID-19 Infection.
Acta Dermatovenerol Croat. 2022 Dec;30(4):265-266.
4
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
5
Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Immun Inflamm Dis. 2023 Apr;11(4):e804. doi: 10.1002/iid3.804.
6
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
7
Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e619-e620. doi: 10.1111/jdv.17409. Epub 2021 Jun 7.
8
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?
J Med Virol. 2022 Apr;94(4):1292-1293. doi: 10.1002/jmv.27535. Epub 2021 Dec 31.
9
Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
Dermatol Ther. 2022 Feb;35(2):e15256. doi: 10.1111/dth.15256. Epub 2021 Dec 26.
10
Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
J Dtsch Dermatol Ges. 2022 Aug;20(8):1123-1124. doi: 10.1111/ddg.14784. Epub 2022 Jun 14.
引用本文的文献
1
Epidemiology, Symptoms and Pathophysiology of Long Covid Complications.
J Cell Immunol. 2024;6(5):219-230. doi: 10.33696/immunology.6.209.
2
A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation.
Indian J Dermatol. 2024 Mar-Apr;69(2):145-151. doi: 10.4103/ijd.ijd_1071_23. Epub 2024 Apr 29.
3
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
4
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
Life (Basel). 2023 Apr 18;13(4):1037. doi: 10.3390/life13041037.
5
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
6
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
7
Clinical Patterns and Morphology of COVID-19 Dermatology.
Dermatol Clin. 2021 Oct;39(4):487-503. doi: 10.1016/j.det.2021.05.006. Epub 2021 May 31.
8
Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4097-4098. doi: 10.1080/21645515.2021.1963173. Epub 2021 Aug 26.
9
Pityriasis Rosea in a Confirmed COVID-19 Pediatric Patient.
Actas Dermosifiliogr. 2021 Oct;112(9):864-865. doi: 10.1016/j.adengl.2021.07.006. Epub 2021 Jul 14.
10
Skin disorders associated with the COVID-19 pandemic: A review.
J Cosmet Dermatol. 2021 Oct;20(10):3105-3115. doi: 10.1111/jocd.14266. Epub 2021 Jul 1.
本文引用的文献
1
Herpes zoster following COVID-19: a report of three cases.
Eur J Dermatol. 2020 Dec 1;30(6):754-756. doi: 10.1684/ejd.2020.3924.
2
Pityriasis rosea-like eruption revealing COVID-19.
Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504. Epub 2020 Nov 20.
3
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
4
Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Med Clin (Barc). 2020 Sep 25;155(6):273. doi: 10.1016/j.medcli.2020.05.024. Epub 2020 Jun 5.
5
SARS-CoV-2 as possible inducer of viral reactivations.
Dermatol Ther. 2020 Nov;33(6):e13878. doi: 10.1111/dth.13878. Epub 2020 Jul 6.
6
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
7
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
Zotero 插件